Hapvida has fallen a very long way. Shares of the healthcare provider are down 95% from their 2021 peak, wiping out more than $16 billion in market value. Over the last 12 months, it’s the worst-performing stock in Brazil’s benchmark equity index by far.
After 95% Drop, Brazil’s Worst Stock Is Ready for a Makeover
Hapvida has fallen a very long way. Shares of the healthcare provider are down 95% from their 2021 peak, wiping out more than $16 billion in market value. Over the last 12 months, it’s the worst-performing stock in Brazil’s benchmark…
This article was originally published by
Bloomberg Markets
and is republished here under license.
Leave a Reply